Two-birds-one-stone strategy shows promise in RNA-repeat expansion diseases
JUPITER, FL–A new strategy for treating a variety of diseases known as RNA-repeat expansion disorders, which affect millions of people, has shown promise in proof-of-principle tests conducted by scientists at Scripps Research. The results suggest that someday, a handful of well-targeted drugs might be able to treat the more than 40 human disorders–including Huntington’s disease…